This company listing is no longer active
IS8 Stock Overview
Develops and sells software products for ophthalmology worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ifa systems AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.80 |
| 52 Week High | €4.46 |
| 52 Week Low | €2.58 |
| Beta | 0.88 |
| 11 Month Change | 0% |
| 3 Month Change | 8.53% |
| 1 Year Change | -26.32% |
| 33 Year Change | -65.00% |
| 5 Year Change | -12.50% |
| Change since IPO | -83.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| IS8 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.3% | 0.8% |
| 1Y | -26.3% | -31.3% | 9.1% |
Return vs Industry: IS8 underperformed the German Healthcare Services industry which returned 5.1% over the past year.
Return vs Market: IS8 underperformed the German Market which returned 9.5% over the past year.
Price Volatility
| IS8 volatility | |
|---|---|
| IS8 Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IS8 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IS8's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 73 | n/a | www.ifasystems.de |
ifa systems AG develops and sells software products for ophthalmology worldwide. It offers an electronic patient file that allows data documentation from the examinations and treatments. The company’s products include ifa Lion for patient documentation and administration work; and ifa Managed Security that provides IT security solutions, such as firewall, backup, and endpoint solutions.
ifa systems AG Fundamentals Summary
| IS8 fundamental statistics | |
|---|---|
| Market cap | €7.26m |
| Earnings (TTM) | €448.00k |
| Revenue (TTM) | €8.67m |
16.2x
P/E Ratio0.8x
P/S RatioIs IS8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IS8 income statement (TTM) | |
|---|---|
| Revenue | €8.67m |
| Cost of Revenue | €6.06m |
| Gross Profit | €2.61m |
| Other Expenses | €2.16m |
| Earnings | €448.00k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 30.08% |
| Net Profit Margin | 5.17% |
| Debt/Equity Ratio | 0% |
How did IS8 perform over the long term?
See historical performance and comparison